In vivo MR spectroscopy reflects synapse density in a Huntington's disease mouse model

Striatal medium spiny neurons are highly susceptible in Huntingtons disease (HD), resulting in progressive synaptic perturbations that lead to neuronal dysfunction and death. Non-invasive imaging techniques, such as proton magnetic resonance spectroscopy (1H-MRS), are used in HD mouse models and patients with HD to monitor neurochemical changes associated with neuronal health. However, the association between brain neurochemical alterations and synaptic dysregulation is unknown, limiting our ability to monitor potential treatments that may affect synapse function. We conducted in vivo longitudinal 1H-MRS in the striatum followed by ex-vivo analyses of excitatory synapse density of two synaptic circuits disrupted in HD, thalamo-striatal (T-S) and cortico-striatal (C-S) pathways, to assess the relationship between neurochemical alterations and changes in synapse density. We used the zQ175(Tg/0) HD mouse model as well as zQ175 mice lacking one allele of CK2(zQ175(Tg/0):CK2(+/-)), a kinase previously shown to regulate synapse function in HD. Longitudinal analyses of excitatory synapse density showed early and sustained reduction in T-S synapses in zQ175 mice, preceding C-S synapse depletion, which was rescued in zQ175:CK2(+/-). Changes in T-S and C-S synapses were accompanied by progressive alterations in numerous neurochemicals between WT and HD mice. Linear regression analyses showed C-S synapse number positively correlated with 1H-MRS-measured levels of GABA while T-S synapse number positively correlated with levels of alanine, phosphoethanolamine and lactate, and negatively correlated with total creatine levels. These associations suggest that these neurochemical concentrations measured by 1H-MRS may facilitate monitoring circuit-specific synaptic dysfunction in the zQ175 mouse model and in other HD pre-clinical studies. Significance StatementThe pathogenic events of many neurodegenerative diseases including HD are triggered by reductions in number of synapses. Therefore, in vivo measures that reflect synapse number represent a powerful tool to monitor synaptic changes in numerous brain disorders. In this study, we showed that non-invasive in vivo 1H-MRS reflects excitatory synapse number in the striatum of the zQ175 mouse model of HD. The combination of longitudinal 1H-MRS and immunofluorescence synapse detection revealed that distinct neurochemical levels significantly correlated with different striatal glutamatergic synaptic input pathways, suggesting that 1H-MRS could distinguish circuit-dependent synapse changes in HD. These results provide potential neurochemical biomarkers to monitor synaptic changes in future pre-clinical trials with HD models.